Period:
Draw Mode:
| Volume | 7,230,531 |
|
|||||
| News | - | ||||||
| Day High | 104.68 | Low High |
|||||
| Day Low | 102.71 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.35 | -1.29% | 102.95 | 16:42:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 104.36 | 102.71 | 104.68 | 102.95 | 104.30 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 76,906 | 7,230,531 | $ 103.52 | $ 748,481,721 | - | 86.02 - 119.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:43:46 | bunched | 175,921 | $ 102.95 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 261.24B | 2.54B | - | 59.28B | 14.52B | 5.72 | 18.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 107.18 | 107.22 | 102.71 | 105.17 | 5,372,983 | -4.23 | -3.95% |
| 1 Month | 109.81 | 110.37 | 102.71 | 107.24 | 6,015,896 | -6.86 | -6.25% |
| 3 Months | 111.40 | 112.02 | 102.71 | 107.54 | 6,864,647 | -8.45 | -7.59% |
| 6 Months | 105.63 | 119.65 | 102.71 | 110.42 | 6,910,345 | -2.68 | -2.54% |
| 1 Year | 87.00 | 119.65 | 86.02 | 107.14 | 8,023,408 | 15.95 | 18.33% |
| 3 Years | 82.45 | 119.65 | 70.89 | 87.36 | 10,351,996 | 20.50 | 24.86% |
| 5 Years | 71.07 | 119.65 | 65.25 | 84.37 | 10,373,800 | 31.88 | 44.86% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |